Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.
Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
Palbociclib (Ibrance®) is an oral therapy for postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
Panobinostat (Farydak ®) is an oral chemotherapy given in combination with other medications for the treatment of several types of cancers.
It’s summertime - that means fun, sun and vacations! Just because you are going through cancer treatment doesn’t mean you can’t take a vacation. Watch the Cancer Goes to the Beach webinar to get tips and resources to plan a safe and stress free getaway. July is also UV Safety Month – learn all you need to know to stay sun safe this summer.
Jul 30, 2015
No significant association seen between telomere length and other types of cancer
Jul 31, 2015
But rarely seen after treatment; correlations for persistent HPV16 DNA with worse survival
Jul 29, 2015
Low-cost HRME ups accuracy of Lugol's chromoendoscopy for esophageal cancer
Jul 31, 2015
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Our award winning cancer education content is now available for licensing and syndication.
Please help us to better understand skin cream usage for patients who develop skin redness/irritation during radiation therapy. We are very interested in the opinions and experience of both patients and providers regarding skin cream usage for radiation-related skin reactions. Your participation in this survey would be much appreciated.